Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;56(5):892-893.
doi: 10.1111/apt.17143.

Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome

Eric D Shah  1 , Emily V Wechsler  1
Affiliations
Editorial

Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome

Eric D Shah et al. Aliment Pharmacol Ther. 2022 Sep.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Shah ED, Siegel CA. Systems-based strategies to consider treatment costs in clinical practice. Clin Gastroenterol Hepatol. 2020;18(5):1010-4. https://doi.org/10.1016/j.cgh.2020.02.030
    1. Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, et al. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(2):117-31.
    1. Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, et al. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 2020;69(1):74-82. https://doi.org/10.1136/gutjnl-2018-318160
    1. Shah ED, Salwen-Deremer JK, Gibson PR, Muir JG, Eswaran S, Chey WD. Comparing costs and outcomes of treatments for irritable bowel syndrome with diarrhea: cost-benefit analysis. Clin Gastroenterol Hepatol. 2020;20:136-144.e31. https://doi.org/10.1016/j.cgh.2020.09.043
    1. Shah ED, Salwen-Deremer JK, Gibson PR, Muir JG, Eswaran S, Chey WD. Pharmacologic, dietary, and psychological treatments for irritable bowel syndrome with constipation: cost utility analysis. MDM Policy Pract. 2021;6(1):2381468320978417. https://doi.org/10.1177/2381468320978417